Pyrexia, commonly known as fever, is a clinical symptom frequently encountered in medical practice. It is a physiological response to a variety of conditions, most commonly infectious diseases. Understanding the pathophysiology, identifying the cause, and managing fever effectively are critical to patient care.
Pyrexia is the body's adaptive response to pathologic conditions, primarily infections. The hypothalamus, acting as the body's thermostat, raises the set-point temperature in response to pyrogens. These can be endogenous, such as cytokines, or exogenous like microbial toxins. This results in the characteristic symptoms of fever.
Identifying the cause of pyrexia is crucial for targeted treatment. A detailed history and physical examination often provide valuable clues. Laboratory tests, including complete blood count, cultures, and imaging studies, may be necessary in some cases. Infections are the most common cause, but non-infectious causes such as malignancies, autoimmune diseases, and drug reactions should also be considered.
Management of pyrexia involves treating the underlying cause and symptomatic relief. Antipyretics, such as paracetamol and non-steroidal anti-inflammatory drugs, are commonly used for symptomatic relief. However, their use should be balanced against potential side effects. In cases where the cause of fever is unclear, empirical antimicrobial therapy may be initiated while investigations are ongoing.
Management of pyrexia may differ in special populations, such as children, pregnant women, and immunocompromised patients. In these groups, the risk of serious infections is higher, and a more cautious approach is often warranted. Additionally, the choice of antipyretics may be limited due to safety concerns.
Pyrexia is a common clinical symptom with a wide range of causes. A systematic approach to identifying the cause and managing the fever effectively is essential. Further research is needed to refine our understanding of the pathophysiology of fever and to develop more effective antipyretic therapies.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation